HC Wainwright & Co. reiterated coverage on TherapeuticsMD with a new price target

11/12/21 6:03:07 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of TherapeuticsMD with a rating of Buy and set a new price target of $3.00 from $4.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TXMD

Date	Price Target	Rating	Analyst
3/11/2022	$3.00 → $2.50	Buy	HC Wainwright & Co.
11/12/2021	$4.00 → $3.00	Buy	HC Wainwright & Co.